{"id":"https://openalex.org/W1994974331","doi":"https://doi.org/10.1001/jamaoncol.2015.0565","title":"Therapeutic Advances and Treatment Options in Metastatic Melanoma","display_name":"Therapeutic Advances and Treatment Options in Metastatic Melanoma","publication_year":2015,"publication_date":"2015-04-23","ids":{"openalex":"https://openalex.org/W1994974331","doi":"https://doi.org/10.1001/jamaoncol.2015.0565","mag":"1994974331","pmid":"https://pubmed.ncbi.nlm.nih.gov/26181188"},"language":"en","primary_location":{"id":"doi:10.1001/jamaoncol.2015.0565","doi":"https://doi.org/10.1001/jamaoncol.2015.0565","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2015.0565","pdf_url":null,"source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Douglas B. Johnson","raw_affiliation_strings":["Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee2Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee","Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee2Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075566772","display_name":"Jeffrey Alan Sosman","orcid":"https://orcid.org/0000-0002-0650-9698","observed_orcids":["https://orcid.org/0000-0002-0650-9698"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Sosman","raw_affiliation_strings":["Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee2Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee","Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee2Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5025067315"],"corresponding_institution_ids":["https://openalex.org/I901861585"],"apc_list":null,"apc_paid":null,"fwci":5.2049,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.96604866,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"1","issue":"3","first_page":"380","last_page":"380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.949999988079071},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/combination-targeted-therapy","display_name":"combination targeted therapy","score":0.7009999752044678},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8569999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pd-1-pd-l1","display_name":"PD-1/PD-L1","score":0.9829999804496765},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7519999742507935},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8259999752044678},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9042946100234985},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.727683961391449},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6701014637947083},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.5340321063995361},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49477142095565796},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46290668845176697},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.41139352321624756},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39081138372421265},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34133803844451904},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33105915784835815},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.24411514401435852}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019139","descriptor_name":"Tumor Escape","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jamaoncol.2015.0565","doi":"https://doi.org/10.1001/jamaoncol.2015.0565","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2015.0565","pdf_url":null,"source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},{"id":"pmid:26181188","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26181188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G457800531","display_name":null,"funder_award_id":"K12 CA 0906525","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":73,"referenced_works":["https://openalex.org/W131280268","https://openalex.org/W1804117510","https://openalex.org/W1842966157","https://openalex.org/W1950572133","https://openalex.org/W1965370740","https://openalex.org/W1967084952","https://openalex.org/W1977889509","https://openalex.org/W1984521423","https://openalex.org/W1984592499","https://openalex.org/W1985850253","https://openalex.org/W1988379285","https://openalex.org/W1990011632","https://openalex.org/W1990675339","https://openalex.org/W2005354746","https://openalex.org/W2024117515","https://openalex.org/W2034048944","https://openalex.org/W2038325530","https://openalex.org/W2038434969","https://openalex.org/W2039123767","https://openalex.org/W2040956995","https://openalex.org/W2053520756","https://openalex.org/W2096223992","https://openalex.org/W2096387850","https://openalex.org/W2097995306","https://openalex.org/W2099034576","https://openalex.org/W2100158834","https://openalex.org/W2103152130","https://openalex.org/W2104885590","https://openalex.org/W2105660237","https://openalex.org/W2106494998","https://openalex.org/W2106543129","https://openalex.org/W2107484016","https://openalex.org/W2109387929","https://openalex.org/W2111404068","https://openalex.org/W2112601576","https://openalex.org/W2116978375","https://openalex.org/W2118982164","https://openalex.org/W2119198740","https://openalex.org/W2121545342","https://openalex.org/W2121820529","https://openalex.org/W2123363005","https://openalex.org/W2124427232","https://openalex.org/W2128035403","https://openalex.org/W2128327828","https://openalex.org/W2128542677","https://openalex.org/W2129088290","https://openalex.org/W2131040858","https://openalex.org/W2133075384","https://openalex.org/W2135707184","https://openalex.org/W2136474966","https://openalex.org/W2136746908","https://openalex.org/W2137020485","https://openalex.org/W2143163879","https://openalex.org/W2144096834","https://openalex.org/W2146772089","https://openalex.org/W2147474070","https://openalex.org/W2147482894","https://openalex.org/W2149642154","https://openalex.org/W2154441168","https://openalex.org/W2154841567","https://openalex.org/W2155461614","https://openalex.org/W2156078931","https://openalex.org/W2160834915","https://openalex.org/W2163188200","https://openalex.org/W2164918836","https://openalex.org/W2166262263","https://openalex.org/W2168143310","https://openalex.org/W2211214375","https://openalex.org/W2245845154","https://openalex.org/W2320537501","https://openalex.org/W2404196663","https://openalex.org/W2406957937","https://openalex.org/W4244304327"],"related_works":["https://openalex.org/W2601908725","https://openalex.org/W1916356108","https://openalex.org/W2605233023","https://openalex.org/W2885608817","https://openalex.org/W2190782500","https://openalex.org/W1967000639","https://openalex.org/W2346862687","https://openalex.org/W1986494983","https://openalex.org/W2059346549","https://openalex.org/W1819952509"],"abstract_inverted_index":{"Over":[0],"the":[1,13,30,53,81,88,143],"past":[2],"several":[3],"years,":[4],"management":[5],"of":[6,17,33,45,55,90,128,145],"advanced":[7],"melanoma":[8],"has":[9,75,86],"been":[10,49,122],"transformed":[11],"by":[12,113],"development":[14,89,144],"and":[15,61,67,74,131,148,155],"approval":[16],"novel":[18],"therapeutic":[19],"approaches.":[20],"Genetically":[21],"targeted":[22,147],"therapies":[23],"are":[24,132],"now":[25,76],"effective":[26],"treatment":[27],"options":[28],"for":[29],"approximately":[31],"50%":[32],"patients":[34],"whose":[35],"melanomas":[36],"harbor":[37],"activating":[38],"point":[39],"mutations":[40],"in":[41,135],"BRAF.":[42],"Combination":[43],"regimens":[44],"small-molecule":[46],"inhibitors":[47,73,98],"have":[48,121],"developed":[50,134],"to":[51],"delay":[52],"onset":[54],"acquired":[56],"resistance.":[57],"Specifically,":[58],"combined":[59],"BRAF":[60,72],"MEK":[62],"inhibition":[63],"improves":[64],"response":[65],"rates":[66],"survival":[68],"compared":[69],"with":[70,92,124],"single-agent":[71],"received":[77],"regulatory":[78],"approval.":[79],"During":[80],"same":[82],"time":[83],"frame,":[84],"excitement":[85],"surrounded":[87],"immunotherapy":[91],"checkpoint":[93,97],"inhibitors.":[94],"New":[95],"immune":[96,117,149],"blocking":[99],"cytotoxic":[100],"T":[101],"lymphocyte":[102],"antigen-4":[103],"(CTLA4)":[104],"or":[105],"programmed":[106],"death-1":[107],"receptor/ligand":[108],"(PD-1/PD-L1)":[109],"improve":[110],"patient":[111,153],"outcomes":[112],"promoting":[114],"an":[115,125],"antitumor":[116],"response.":[118],"These":[119],"agents":[120],"associated":[123],"increasing":[126],"number":[127],"durable":[129],"responses":[130],"being":[133],"various":[136],"combinations.":[137],"In":[138],"this":[139],"review,":[140],"we":[141],"discuss":[142],"these":[146],"therapies,":[150],"review":[151],"current":[152],"management,":[154],"highlight":[156],"future":[157],"directions.":[158]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}